The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports

被引:33
作者
Roberts, MTM
Mendelson, M
Meyer, P
Carmichael, A
Lever, AML
机构
[1] Addenbrookes Hosp, Dept Infect Dis, Cambridge CB2 2QQ, England
[2] Addenbrookes Hosp, Dept Ophthalmol, Cambridge CB2 2QQ, England
关键词
thalidomide; tuberculous meningitis; tuberculomas; tuberculosis;
D O I
10.1016/S0163-4453(03)00077-X
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We present two cases of tuberculous meningitis (TBM) in adults complicated by focal neurological deficits which showed progression whilst on steroids. In case 1 an MRI demonstrated multiple ring-enhancing lesions compressing the optic chiasm leading to a bitemporal hemianopia. After the introduction of thalidomide serial imaging and field perimetry at 6, 9, 12 and 24 months into treatment showed progressive improvement. In case 2, two months into anti-tuberculous treatment with steroids, the patient developed fluctuating right sided paralysis with the MRI demonstrating a large ring-enhancing mass encasing the left internal carotid and middle cerebral arteries. Thalidomide was introduced as an immunomodulatory adjunct and subsequently the patient made a complete neurological recovery. The immunomodulatory effects of thalidomide may have a role in the acute and chronic management of TBM complicated by intracranial tuberculomas. (C) 2003 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:251 / 255
页数:5
相关论文
共 16 条
[1]   PARADOXICAL ENLARGEMENT OR DEVELOPMENT OF INTRACRANIAL TUBERCULOMAS DURING THERAPY - CASE-REPORT AND REVIEW [J].
AFGHANI, B ;
LIEBERMAN, JM .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (06) :1092-1099
[2]   Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease [J].
Gori, A ;
Rossi, MC ;
Marchetti, G ;
Trabattoni, D ;
Molteni, C ;
Cogliati, M ;
Bandera, A ;
Clerici, M ;
Franzetti, F .
AIDS, 2000, 14 (12) :1859-1861
[3]   Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset [J].
Haslett, PAJ ;
Corral, LG ;
Albert, M ;
Kaplan, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) :1885-1892
[4]  
HORNE HW, 1966, BIBL TUBERC, V22, P1
[5]   Thalidomide and its analogues have distinct and opposing effects on TNF-α and TNFR2 during co-stimulation of both CD4+ and CD8+ T cells [J].
Marriott, JB ;
Clarke, IA ;
Dredge, K ;
Muller, G ;
Stirling, D ;
Dalgleish, AG .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (01) :75-84
[6]  
MARSHALL G, 1948, LANCET, V254, P582
[7]  
Miyoshi Y, 2000, Rinsho Shinkeigaku, V40, P1018
[8]   Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis [J].
Moreira, AL ;
Tsenova-Berkova, L ;
Wang, J ;
Laochumroonvorapong, P ;
Freeman, S ;
Freedman, VH ;
Kaplan, G .
TUBERCLE AND LUNG DISEASE, 1997, 78 (01) :47-55
[9]  
PRASAD K, 2000, COCHRANE DB SYST REV, V3
[10]   THE INFLUENCE OF THALIDOMIDE ON THE CLINICAL AND IMMUNOLOGICAL MANIFESTATION OF ERYTHEMA-NODOSUM LEPROSUM [J].
SAMPAIO, EP ;
KAPLAN, G ;
MIRANDA, A ;
NERY, JAC ;
MIGUEL, CP ;
VIANA, SM ;
SARNO, EN .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) :408-414